Huntington is a regional US bank with over $285 billion in assets... Show more
Huntington Bancshares (HBAN) has traded with a clear upward bias over the past month, recovering from a mid-May trough near $15.35 to reach levels above $18 in mid-July. The stock currently sits about 6% below its 52-week high of $19.45 and well above its 52-week low of $14.89. The 50-day moving average of $16.90 and 200-day moving average of $16.92 are both comfortably below the current price, signaling positive technical momentum. With a market capitalization of approximately $37 billion and a P/E ratio of roughly 14, HBAN trades at a modest discount to several regional banking peers — a dynamic some analysts attribute to lingering M&A-related uncertainty. The stock also offers a quarterly dividend of $0.155 per share, translating to an annualized yield of about 3.4%.
Huntington Bancshares Incorporated is a Columbus, Ohio-based regional bank holding company whose principal subsidiary, The Huntington National Bank, traces its roots back to 1866. The bank serves individual consumers, small and middle-market businesses, corporations, and municipalities through a comprehensive suite of banking, payments, wealth management, and risk management services. Following the completion of its Cadence Bank acquisition, Huntington now operates over 1,400 branches across 21 states, commanding roughly $285 billion in total assets. The merger significantly deepened the bank's presence in high-growth Sun Belt markets, particularly Texas and the Southeast. Core business lines include consumer and commercial lending, mortgage origination and servicing, auto financing, deposit products, treasury management, and wealth advisory services. Investors follow HBAN closely as a bellwether for regional bank performance, especially given its expanding geographic diversification and disciplined capital return framework.
Several catalysts have shaped HBAN's narrative over the past 30 days. The company's Q1 2026 earnings report, released April 23, delivered a substantial beat as adjusted EPS of $0.37 trounced the $0.16 consensus by over 130%. Net interest income surged 33% year-over-year to $1.89 billion, reflecting improved lending profitability and early benefits from the Cadence integration. Management also highlighted the potential release of up to $1 billion in capital under proposed regulatory changes.
In June, Evercore ISI raised its price target to $20 and Stephens initiated coverage with an Equal Weight rating and a $19 target. However, Jefferies downgraded the stock to Hold from Buy on July 6, citing near-term headwinds tied to deal integration and uncertainty around deposit costs and net interest margin. Conversely, JPMorgan raised its target to $19.50 with an Overweight rating, UBS lifted its target to $22, and RBC boosted its target to $21 — reflecting a divided but net-positive analyst community.
The company also paid its quarterly dividend of $0.155 per share on July 1 and continues executing against its $3 billion share repurchase program. Insiders have been net sellers in recent weeks, with Director James D. Rollins III selling 223,522 shares in mid-June and EVP Marcy C. Hingst selling 10,568 shares in late June, though both transactions were conducted under pre-arranged Rule 10b5-1 trading plans.
For traders seeking data-driven strategies, Tickeron's Trending AI Robots page offers a curated view of the platform's top-performing AI-powered trading bots. Tickeron hosts hundreds of algorithmic trading bots that monitor thousands of tickers across various strategies, timeframes, and performance metrics. The Trending section filters out noise by spotlighting only the most relevant and consistently high-performing bots, allowing users to observe real-time signal generation, track win rates, and evaluate trade history at a glance. Whether a bot focuses on short-term momentum, swing trading, or longer-term trend following, each one operates autonomously using pattern recognition and technical analysis. Exploring the Trending AI Robots page can help investors identify actionable perspectives grounded in quantitative logic rather than emotion.
The primary near-term event for HBAN shareholders is the Q2 2026 earnings release scheduled for July 23. Analysts expect $0.39 per share in adjusted EPS and roughly $2.84 billion in revenue. Key areas of focus will include net interest margin trends, deposit cost management, loan growth across legacy and newly acquired markets, and management's updated guidance on Cadence integration synergies.
Macroeconomic factors will also play a decisive role. The Federal Reserve's interest rate trajectory, regional economic health in the Midwest and Southeast, and overall credit quality in commercial and consumer loan portfolios remain central variables. Investors should also monitor capital return activity, including the pace of share repurchases under the $3 billion authorization, and any updates regarding regulatory capital reform that could free up additional balance sheet capacity. While consensus analyst sentiment leans bullish, the stock's ability to break convincingly above its 52-week high of $19.45 will likely depend on the strength of forward guidance and tangible evidence that post-merger execution is on track.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
The 10-day RSI Indicator for HBAN moved out of overbought territory on July 17, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 instances where the indicator moved out of the overbought zone. In of the 37 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
HBAN broke above its upper Bollinger Band on July 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on July 13, 2026. You may want to consider a long position or call options on HBAN as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HBAN just turned positive on July 16, 2026. Looking at past instances where HBAN's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
The 50-day moving average for HBAN moved above the 200-day moving average on June 30, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HBAN advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 272 cases where HBAN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. HBAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.235) is normal, around the industry mean (1.372). P/E Ratio (13.896) is within average values for comparable stocks, (18.378). Projected Growth (PEG Ratio) (2.130) is also within normal values, averaging (1.995). Dividend Yield (0.034) settles around the average of (0.031) among similar stocks. P/S Ratio (3.310) is also within normal values, averaging (3.957).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock slightly better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks